Overall, it seems prudent to choose a lower-risk antipsychotic such as aripiprazole or ziprasidone for an individual who has preexisting DM or is otherwise at high risk. If hyperglycemia, dyslipidemia, and/or substantial weight gain develops, switching to a lower-risk antipsychotic drug should be considered.[6,14]While data regarding potential metabolic consequences of long-term treatment with newer SGAs (such as asenapine, iloperidone, lurasidone, and paliperidone) are currently lacking, the relative effects of these agents on the development of diabetes and other metabolic derangements will become more clear with additional study and clinical experience.